Non-canonical Hedgehog signaling contributes to chemotaxis in cholangiocarcinoma
Nataliya Razumilava(University of Michigan), Gregory J. Gores(Mayo Clinic in Arizona), Sergio A. Gradilone(University of Minnesota), Joachim C. Mertens(GastroZentrum Hirslanden Zürich), Steven F. Bronk(Mayo Clinic), Rory L. Smoot(Pancreas Centre (Canada)), Alphonse E. Sirica(Virginia Commonwealth University)
Cited by 80
Related Papers
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2016|2.7k
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2008|1.7k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k